SLC2A1 and cancer: HIF-1α then induces the expression of GLUT1, HK and ALDOA to accelerate glycolysis rate and subsequently promote cancer cell invasion and migration through mechanisms involving EMT and chemoradiotherapy resistance that ultimately lead to poor survival outcomes 9, 10.